Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Irinotecan × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 62 Pancreatic Neoplasms 29 Neoplasm Metastasis 20 Neuroblastoma 16 Colonic Neoplasms 16 Neoplasms 15 Stomach Neoplasms 13 Rectal Neoplasms 9 Sarcoma, Ewing 8 Rhabdomyosarcoma 7 Esophageal Squamous Cell Carcinoma 7 Ovarian Neoplasms 6 Sarcoma 5 Adenocarcinoma Of Esophagus 5 Small Cell Lung Carcinoma 4 Medulloblastoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Endometrial Neoplasms 4 Cholangiocarcinoma 4 Breast Neoplasms 4 Recurrence 3 Osteosarcoma 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Ependymoma 3 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2

Interventions

Nivolumab 6 Ipilimumab 5 Cisplatin 5 atezolizumab 4 Carboplatin 4 Etoposide 3 gallium Ga 68 dotatate 2 dostarlimab 2 Temozolomide 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Drug Therapy 2 Disulfides 2 zimberelimab 1 tivozanib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 niraparib 1 lutetium Lu 177 dotatate 1 iadademstat 1 durvalumab 1 cabozantinib 1 budigalimab 1 berzosertib 1 belinostat 1 Topotecan 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡